ULTRAGENYX PHARMACEUTICAL IN (RARE) Stock Analyst Ratings
NASDAQ:RARE - Nasdaq - US90400D1081 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to RARE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 96.31. This target is 126.13% above the current price.
RARE was analyzed by 26 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RARE.
In the previous month the buy percentage consensus was at a similar level.
RARE was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-13 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-01-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-21 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-05 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-02 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-08-02 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-08-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-07-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-18 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-06-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-06 | Goldman Sachs | Upgrade | Neutral -> Buy |